UNSPSC 41202015: Cryptococcus neoformansserological reagents

In this classification, Cryptococcus neoformans serological reagents are devices used in test to identify specific Cryptococcus neoformans antibodies in serum. US FDA regulates Cryptococcus neoformans serological reagents under 21 CFR 866.3165 and under FDA product code GME.

UNSPSC 41202015 Cryptococcus neoformans serological reagents is a Commodity code that does not align with the recent state and local procurement activity filed under it. The most recent opportunities posted under this code involve HIV and Syphilis testing kits, forensic specimen analysis, clinical blood chemistry reagents, and pool maintenance services—none of which relate to Cryptococcus neoformans serological testing. The Illinois Department of Public Health has conducted emergency procurements for Abbott Laboratories HIV and Syphilis reagents, with one contract valued at $38,079.50 executed in February 2026, and a separate competitive IFB for a five-year statewide contract for combined Hepatitis/HIV/Syphilis screening assay instrumentation posted in February 2026 with a March 16, 2026 response deadline. The City of Austin issued an IFB for rapid HIV test kits (Abbott Determine HIV 1/2) due July 17, 2026, and Collin County Community Supervision and Corrections Department solicited offender drug testing and specimen collection services via RFP 2026-327, due July 23, 2026, with an estimated contract value of $600,000 and a September 1, 2026 start date. These opportunities reflect actual procurement demand under this code in real time.

Activity is concentrated in Texas and Illinois, with recent solicitations also appearing in Texas Department of Criminal Justice forensic laboratory services (RFP 696-IG-26-P034, due May 13, 2026) and clinical laboratory diagnostics at the University of Houston (RFP-730-UofH-3109, due March 24, 2026). Issuing bodies include state health departments, county corrections and community supervision agencies, municipal public health programs, and higher-education institutions. However, the code designation appears to be a data-entry error or miscategorization—the posted opportunities show no procurement activity specific to Cryptococcus neoformans testing or serological reagents for that organism. Prospective vendors should verify code assignment and actual commodity scope before pursuing opportunities filed under this code, as the mismatch between the code name and the work being bought creates substantial risk of wasted proposal effort.